TRAVERE THERAPEUTICS INC's ticker is and the CUSIP is 89422GAA5. A total of 24 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $647,930 | – | 1,000,000 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 45,000,000 | $474,089,000 | 9.50% |
ABSOLUTE INVESTMENT ADVISERS, LLC | 4,000,000 | $4,280,000 | 0.96% |
DeepCurrents Investment Group LLC | 22,150,000 | $23,650,000 | 0.74% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 19,000,000 | $19,967,000 | 0.46% |
Context Capital Management, LLC | 5,750 | $6,138,000 | 0.40% |
WOLVERINE ASSET MANAGEMENT LLC | 34,000,000 | $36,271,000 | 0.35% |
Polar Asset Management Partners Inc. | 15,000,000 | $15,993,000 | 0.17% |
LINDEN ADVISORS LP | 20,000,000 | $21,281,000 | 0.13% |
Wellesley Asset Management | 1,599 | $1,599,000 | 0.11% |
Verition Fund Management LLC | 6,213,000 | $6,614,000 | 0.08% |